Reena has over 20 years of work experience in strategic consulting spanning both commercial and scientific analysis.
At Putnam/SmartAnalyst for ~15 years, she has led 100+ projects for leading global pharma companies and biotechs in oncology, covering the breadth of solid tumors and hematological malignancies. Her core work has focused on mapping strategic solutions through scientific assessment of emerging technologies, targets and modalities, opportunity prioritization driven by disease area and asset strategy, due diligence for licensing / acquisition propositions, developing and testing target product profiles, while closely tracking market innovation. She has also co-led portfolio optimization projects for both big pharma and biotechs.
With a double Masters degree in Toxicology and Bioinformatics & Biotechnology, she has core domain knowledge in oncology.